Fourteen thought leaders will guide Basepaws through its next stage of growth in becoming a veterinary-centric innovator in pet biotechnology with the goal of making individualized pet care a reality.
Basepaws has officially welcomed 14 members to its newly forged veterinary advisory board who will aid in propelling the company's next phase of growth in the animal health industry.
According to a company release, this dynamic group of advisors are respected by their peers and seasoned experts with diverse backgrounds and more than 20 decades of combined expertise across genetics, dentistry, feline medicine, preventive medicine, general practice, practice management, veterinary information technology, research, veterinary well-being, and social media.
“Our team of veterinary collaborators has empowered Basepaws to become a veterinary-centric innovator in pet biotechnology, making individualized pet care a reality and exploring a wide array of disease-centric areas”, said Kristin Wuhrman, EVP of Business Development and Veterinary Strategy of Basepaws.
The veterinary advisory board members are as follows:
Basepaws is focused on pet biotechnology, specializing in the use of genetics and genomics for the development of health screening tools. Advancements in genomics and computational modeling have changed the way veterinarians understand the relationships between health and disease, and Basepaws is committed to research in this domain to help veterinary professionals provide better care for their patients. Prediction of disease and risk of negative outcomes offer veterinarians greater options in treatment and even prognosis of diseases.
Additionally, the company remains committed to collaborating with veterinarians, universities, and the animal health industry to find solutions to long-standing medical challenges, including genetic and preventable diseases.